BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, February 17, 2026
Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Heading To Clinic, Nereus Adds $18.3M To Series D

March 7, 2006
By Jennifer Boggs

ARCA Gets $15M Series A To Support Bucindolol NDA

March 6, 2006
By Jennifer Boggs

ARCA Gets $15M Series A To Support Bucindolol NDA

March 6, 2006
By Jennifer Boggs

ImQuest Gains Dual-Mechanism HIV Compounds From Samjin

March 1, 2006
By Jennifer Boggs
Though it’s only a month into a strategic drug development agreement between ImQuest Pharmaceuticals Inc. and Samjin Pharmaceutical Co. Ltd., the alliance already has yielded its first licensing deal. (BioWorld Today)
Read More

ImQuest Gains Dual-Mechanism HIV Compounds From Samjin

March 1, 2006
By Jennifer Boggs
Though it’s only a month into a strategic drug development agreement between ImQuest Pharmaceuticals Inc. and Samjin Pharmaceutical Co. Ltd., the alliance already has yielded its first licensing deal. (BioWorld Today)
Read More

Novavax Adding $20M To Support Flu Vaccine Work

Feb. 28, 2006
By Jennifer Boggs

OrthoLogic Broadens Pipeline With AzERx’s ICARM Platform

Feb. 27, 2006
By Jennifer Boggs

Celtic Pharma’s New Acquisition Adds Drug Delivery Technology

Feb. 24, 2006
By Jennifer Boggs
Global private equity firm Celtic Pharmaceutical Holdings LP gained access to a targeted drug delivery technology from IDEA AG, as well as clinical and preclinical products in pain and inflammation, dermatitis and psoriasis. (BioWorld Today)
Read More

Celtic Pharma’s New Acquisition Adds Drug Delivery Technology

Feb. 24, 2006
By Jennifer Boggs
Global private equity firm Celtic Pharmaceutical Holdings LP gained access to a targeted drug delivery technology from IDEA AG, as well as clinical and preclinical products in pain and inflammation, dermatitis and psoriasis. (BioWorld Today)
Read More

CombinatoRx Halts Psoriasis Drug After Its Phase II Failure

Feb. 23, 2006
By Jennifer Boggs
Previous 1 2 … 272 273 274 275 276 277 278 279 280 … 336 337 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing